Screener
Agios Pharmaceuticals AGIO Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 30,152 | 32,920 |
| Contract assets | 4,104 | — |
| Prepaid expenses and other current assets | 45,724 | 44,130 |
| Total current assets | 717,668 | 942,052 |
| Marketable securities | 347,254 | 310,013 |
| Operating lease assets | 23,875 | 30,454 |
| Property and equipment, net | 9,946 | 10,775 |
| Other non-current assets | 9,681 | 3,931 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's total current assets?
- Agios Pharmaceuticals (AGIO) reported total current assets of $717.67M in Q2 2026.
- How has Agios Pharmaceuticals's total current assets changed year-over-year?
- Agios Pharmaceuticals's total current assets decreased by 29.6% year-over-year, from $1.02B to $717.67M.
- What is the long-term trend for Agios Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total current assets has grown at a 8.2% compound annual growth rate (CAGR), from $636.68M to $942.05M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Agios Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude